[Factors influencing the use of health care services from patients with COPD in Chengdu].

Sichuan Da Xue Xue Bao Yi Xue Ban

Department of Epidemiology, West China School of Public Health, Sichuan University, Chengdu 610041, China.

Published: March 2007

Objective: To investigate the use of health care services by COPD patients and to identify factors that shape the pattern of services utilization.

Methods: All of the COPD patients who lived in the six randomly selected communities with community health services in 2003 were surveyed. A total of 446 patients completed the interview-administered questionnaires. The medical records of those patients were also reviewed and abstracted if possible. The questions asked in the survey included: social and demographic information, COPD related knowledge and attitudes, use of health care services and medical expenditure associated with the services in the past year.

Results: About half (53.04%) of the COPD patients used the outpatient services, with an average visits of 6.04 +/- 4.05 per year. Eighteen percent of the patients had been hospitalized, with an average of 6.10 +/- 2.61 episodes of hospitalizations in one year and an average of length of stay of (51.65 +/- 15.91) days. The COPD patients used large comprehensive hospitals (45.33%) more often than the community health services (18.22%). Age, past experiences and attitudes towards COPD, severity of illness and out of pocket payment had significant impact on patients' choice of outpatient services. Occupation, past experiences, out of pocket payment, severity of illness and family attitudes had significant impact on patients' choice of hospital services. Education, income, occupation, out of pocket payment and attitudes towards COPD had significant impact on patients' choice of community health services.

Conclusion: Underutilization of community health services by COPD patients is obvious in Chengdu. Given the diverse range factors that influence patients' choice of services, governmental intervention is needed to encourage the use of community health services.

Download full-text PDF

Source

Publication Analysis

Top Keywords

copd patients
20
community health
20
health services
16
patients' choice
16
services
13
health care
12
care services
12
pocket payment
12
impact patients'
12
patients
9

Similar Publications

Chronic obstructive pulmonary disease (COPD) is a prevalent chronic inflammatory airway disease with high incidence and significant disease burden. R-loops, functional chromatin structure formed during transcription, are closely associated with inflammation due to its aberrant formation. However, the role of R-loop regulators (RLRs) in COPD remains unclear.

View Article and Find Full Text PDF

Objective: To compare the effectiveness and safety of budesonide-glycopyrrolate-formoterol, a twice daily metered dose inhaler, and fluticasone-umeclidinium-vilanterol, a once daily dry powder inhaler, in patients with chronic obstructive pulmonary disease (COPD) treated in routine clinical practice.

Design: New user cohort study.

Setting: Longitudinal commercial US claims data.

View Article and Find Full Text PDF

Pain and Dyspnea During Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Documentation Audit 2019-2020.

J Clin Med

January 2025

Department of Physiotherapy, School of Primary and Allied Health Care, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC 3199, Australia.

Patient-reported outcome measures (PROMs) assess the severity and impact of both pain and dyspnea in those with acute exacerbations of chronic obstructive pulmonary disease (COPD), but their frequency of use in clinical practice is unknown. This study aimed to determine the point prevalence of pain and dyspnea assessment in patients hospitalized with an acute exacerbation of COPD and the measurement tools applied for this purpose in clinical practice. Clinical notes and observation charts of patients admitted with acute exacerbations of COPD to a metropolitan hospital in 2019 and 2020 were retrospectively audited to identify the point prevalence of pain and dyspnea assessment, the PROMs applied, and their associated focal periods.

View Article and Find Full Text PDF

Chronic obstructive pulmonary disease (COPD) is among the most relevant comorbidity associated with lung cancer. The advent of innovative triple treatment approaches for COPD has significantly improved patients' quality of life and outcomes. Few data are available regarding the impact of triple inhaler therapy on patients featuring COPD and lung cancer.

View Article and Find Full Text PDF

Preclinical Identification of Poorly Controlled COPD: Patients with a Single Moderate Exacerbation Matter Too.

J Clin Med

December 2024

Centro de Salud Malilla, Carrer de Malilla 52D, Quatre Carreres, 46026 Valencia, Spain.

Chronic obstructive pulmonary disease (COPD) remains a critical global health challenge, characterized by high morbidity, mortality, and healthcare costs. Current guidelines may overlook patients who present with only one moderate exacerbation or with frequent short-acting beta-agonist (SABA) use. Building on findings from the Seleida study, this research refines the criteria for poor COPD control to include these patients, aiming to improve early identification of high-risk cases in primary care.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!